HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Alfred von Krempelhuber Selected Research

Smallpox Vaccine

4/2015Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
1/2015Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.
1/2015A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
9/2014Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.
3/2013Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.
2/2010A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Alfred von Krempelhuber Research Topics

Disease

6Vaccinia
04/2015 - 02/2010
5Smallpox (Variola)
04/2015 - 03/2013
2Atopic Dermatitis (Atopic Eczema)
01/2015 - 09/2014
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
09/2014

Drug/Important Bio-Agent (IBA)

6Smallpox VaccineFDA Link
04/2015 - 02/2010
5VaccinesIBA
04/2015 - 03/2013
2imvamuneIBA
01/2015 - 02/2010
1AntibodiesIBA
01/2015
1Biological Markers (Surrogate Marker)IBA
03/2013

Therapy/Procedure

1Subcutaneous Injections
01/2015